SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LXR Biotech.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wafa SHIHABI who wrote (116)3/23/1998 6:48:00 AM
From: andy harrison  Read Replies (1) of 154
 
So it isnt so. No way do I or anyone I know who owns LXR want it
bought out at THIS stage. Give it a couple of years to grow and
develope and then well who knows... Imagine if AMGEN got bought
out the day after they filed with the FDA for Epogen and the stock
was non-split adjusted .75 cents?? The best way to make money
in companies with the potential of an LXR is to let it run for several
years.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News